×
Hero Background

IBS Treatment Companies

ID: MRFR/Pharma/4107-CR
69 Pages
Rahul Gotadki
February 2018

In the realm of gastrointestinal health, IBS Treatment companies specialize in developing therapies and interventions for irritable bowel syndrome (IBS). These organizations contribute to

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Irritable Bowel Syndrome (IBS) Treatment Market Research Report - Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the IBS Treatment Market

Irritable Bowel Syndrome (Ibs) Treatment Market

 


Latest Irritable Bowel Syndrome (IBS) Treatment Companies Updates:


Ironwood Pharmaceuticals: Promising Phase 3 data for Linzess (linaclotide) in adult IBS-C patients with constipation-predominant symptoms, potentially expanding treatment options.


Takeda Pharmaceuticals: Positive Phase 2a results for TAK-786, a novel oral guanylate cyclase-C (GC-C) stimulator, showing potential for treating both IBS-C and IBS-D.


Allergan: Launched a Phase 2 study for AG041270, a new investigational therapy targeting neurokinin-1 (NK-1) receptors, for treating IBS-D.


AstraZeneca: Received FDA approval for Trinessa (drospirenone, ethinyl estradiol, and levofloxacin) for treating moderate-to-severe IBS-C in women with endometriosis.


Suven Therapeutics: Launched SB207798, a first-in-class, peripherally acting G-protein coupled receptor 54 (GPR54) agonist, for treating CIC in adults, which could potentially be repurposed for IBS in the future.


Synergy Pharmaceuticals: Expanded market access for Trulance (plecanatide) in Canada for treating adults with IBS-C.


List of Irritable Bowel Syndrome (IBS) Treatment Key companies in the market:



  • Allergan Plc (Ireland)

  • Sucampo Pharmaceuticals (U.S.)

  • Ironwood Pharmaceuticals, Inc. (U.S.)

  • Astellas Pharma Inc. (Japan)

  • Valeant Pharmaceuticals (Canada)

  • Abbott Laboratories (U.S.)

  • Synergy Pharmaceuticals, Inc. (U.S.)

  • Ardelyx, Inc. (U.S.)

  • Nestle (Switzerland)

  • Sebela Pharmaceuticals (Ireland)

  • Probi (Sweden)

  • Alfasigma USA, Inc. (Italy)